Evidence map›Paper›PMID 38256112›Full record

ArticleInternational journal of molecular sciences2024

Computational Design of Novel Griseofulvin Derivatives Demonstrating Potential Antibacterial Activity: Insights from Molecular Docking and Molecular Dynamics Simulation.

Parisa Aris, Masoud Mohamadzadeh, Maaroof Zarei, Xuhua Xia

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Parisa ArisDepartment of Biology, University of Ottawa, 30 Marie Curie, P.O. Box 450, Ottawa, ON K1N 6N5, Canada.ORCID 0000-0003-2774-7035
Masoud MohamadzadehDepartment of Chemistry, Faculty of Sciences, University of Hormozgan, Bandar Abbas 71961, Iran.ORCID 0000-0002-5054-5602
Maaroof ZareiDepartment of Chemistry, Faculty of Sciences, University of Hormozgan, Bandar Abbas 71961, Iran.ORCID 0000-0002-8455-0207
Xuhua XiaDepartment of Biology, University of Ottawa, 30 Marie Curie, P.O. Box 450, Ottawa, ON K1N 6N5, Canada.ORCID 0000-0002-3092-7566
University of Hormozgan · IRUniversity of Ottawa · CA

Funding

Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN/2018-03878
6 · The paper itself

Abstract

In response to the urgent demand for innovative antibiotics, theoretical investigations have been employed to design novel analogs. Because griseofulvin is a potential antibacterial agent, we have designed novel derivatives of griseofulvin to enhance its antibacterial efficacy and to evaluate their interactions with bacterial targets using in silico analysis. The results of this study reveal that the newly designed derivatives displayed the most robust binding affinities towards PBP2, tyrosine phosphatase, and FtsZ proteins. Additionally, molecular dynamics (MD) simulations underscored the notable stability of these derivatives when engaged with the FtsZ protein, as evidenced by root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (Rg), and solvent-accessible surface area (SASA). Importantly, this observation aligns with expectations, considering that griseofulvin primarily targets microtubules in eukaryotic cells, and FtsZ functions as the prokaryotic counterpart to microtubules. These findings collectively suggest the promising potential of griseofulvin and its designed derivatives as effective antibacterial agents, particularly concerning their interaction with the FtsZ protein. This research contributes to the ongoing exploration of novel antibiotics and may serve as a foundation for future drug development efforts.

Indexed as

GriseofulvinMolecular Dynamics SimulationAnti-Bacterial AgentsDrug DevelopmentMolecular Docking SimulationAnti-Bacterial AgentsGriseofulvinantibacterial agentdockingdrug developmentFtsZgriseofulvin derivativesmolecular dynamics

Identifiers

PMID38256112
PMCPMC10816260
OpenAlexW4390881980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.